Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGNX -- MacroGenics -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (68)	11/7/2017 11:50:00 AM
From: tuck	Read Replies (4) \| Respond to of 188

Partially OT >>Have you considered that seller's remorse could be extreme, tril??<< Are you saying folks who sold a few weeks ago are now chasing TRIL stock into bubbliness, or what? Certainly, I left some on the table here. Thought I'd buy a pullback . . . still watching it, of course. Got too much research time invested in it not to look for a re-entry. I could easily see it coming back some. Maybe enough to allow sale of $7.5 puts? OTOH, if it continues to grind higher on continued dribbling out of good news, I'll get wistful. Whatever, I've made decent money on it these past few years. Can't complain. Any thoughts about the MGA012 results from SITC? I don't have enough background in the anti-PD1 space to know how this compares to competing programs at this early stage. Looks mixed, as usual. A fairly decent response rate countered by some AEs >3, and the one SAE is bit troubling. I'd rather it was CRS or some such. Market appears to be yawning over these results, too. Cheers, Tuck